Bcl-2 AS A MARKER FOR OVARIAN CANCER

• Simple to use, noninvasive urine test
• In initial clinical studies Bcl-2 has demonstrated higher sensitivity for detecting early stage of ovarian cancer when compared to CA-125
• This immunoassay can be utilized for accurately predicting success of debulking surgery